HERPES EYE DISEASE

疱疹性眼病

• 批准号: 2163374
• 负责人: ROY W. BECK
• 金额: $ 56.01万
• 依托单位: JAEB CENTER FOR HEALTH RESEARCH, INC.
• 依托单位国家: 美国
• 财政年份: 1992
• 资助国家: 美国
• 起止时间: 1992-08-07 至 2001-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2163374
• 关键词: acyclovir; clinical trials; cooperative study; disease /disorder prevention /control; eye disorder chemotherapy; human subject; human therapy evaluation; iritis; keratitis; ocular herpes; placebos; relapse /recurrence

The Herpetic Eye Disease Study, Phase II, is a multi-institutional study of prevention of ocular herpes simplex infections. Two studies will be randomized comparisons of acyclovir vs. placebo for 1) prevention or delay of recurrences (HEDS-APT) and 2) prevention or delay of stromal keratitis or iritis subsequent to epithelial keratitis (HEDS-EKT). The third study (HEDS-RFS) is a nonexperimental study of potential triggers of recurrence of ocular herpetic disease. This application is to continue the current HEDS Coordinating Center (located at the Proctor Foundation, University of California, San Francisco) as the National Coordinating Center for HEDS Phase II. The National Coordinating Center's responsibilities will include data management, data quality control, statistical analyses, and administrative and technical support to HEDS committees, particularly the Data and Safety Monitoring, Steering, and Executive Committees.

疱疹性眼病研究二期是一项多机构研究